Video
Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction
Author(s):
R. Corey O'Connor, MD, discusses findings from a recent study published in Neurourology and Urodynamics.
In this interview, R. Corey O'Connor, MD, discusses the recent Neurourology and Urodynamics paper, “Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction," for which he served as a study author. O'Connor is associate professor of urology at the Medical College of Wisconsin, Milwaukee.
More videos:
How do OAB patient education materials measure up?
Related Videos
Investigators characterize vibegron prescribing patterns for OAB
Expert outlines advantages of batteryless sacral neuromodulation device
Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI
Smaller size, patient control advantages of neurostimulator for OAB
Batteryless neurostimulator found efficacious at 6-month follow-up
Colin Goudelocke, MD, on 6-month data for batteryless neurostimulator
A physical therapist’s advice for men with post-prostatectomy incontinence
William Furuyama, MD, on community factors’ influence on urinary incontinence
Investigators explore social vulnerability and urinary incontinence
Vanita Gaglani, RPT, discusses books on post-prostatectomy incontinence and prostatitis
Related Content
